411 related articles for article (PubMed ID: 17728375)
1. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.
Koonen DP; Jacobs RL; Febbraio M; Young ME; Soltys CL; Ong H; Vance DE; Dyck JR
Diabetes; 2007 Dec; 56(12):2863-71. PubMed ID: 17728375
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.
Hsieh J; Longuet C; Maida A; Bahrami J; Xu E; Baker CL; Brubaker PL; Drucker DJ; Adeli K
Gastroenterology; 2009 Sep; 137(3):997-1005, 1005.e1-4. PubMed ID: 19482026
[TBL] [Abstract][Full Text] [Related]
3. Hormonal and nutritional regulation of alternative CD36 transcripts in rat liver--a role for growth hormone in alternative exon usage.
Cheung L; Andersen M; Gustavsson C; Odeberg J; Fernández-Pérez L; Norstedt G; Tollet-Egnell P
BMC Mol Biol; 2007 Jul; 8():60. PubMed ID: 17640331
[TBL] [Abstract][Full Text] [Related]
4. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
5. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.
Doege H; Baillie RA; Ortegon AM; Tsang B; Wu Q; Punreddy S; Hirsch D; Watson N; Gimeno RE; Stahl A
Gastroenterology; 2006 Apr; 130(4):1245-58. PubMed ID: 16618416
[TBL] [Abstract][Full Text] [Related]
8. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36.
Habets DD; Coumans WA; Voshol PJ; den Boer MA; Febbraio M; Bonen A; Glatz JF; Luiken JJ
Biochem Biophys Res Commun; 2007 Mar; 355(1):204-10. PubMed ID: 17292863
[TBL] [Abstract][Full Text] [Related]
9. CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors.
Drover VA; Abumrad NA
Biochem Soc Trans; 2005 Feb; 33(Pt 1):311-5. PubMed ID: 15667335
[TBL] [Abstract][Full Text] [Related]
10. Insulin acutely upregulates protein expression of the fatty acid transporter CD36 in human skeletal muscle in vivo.
Corpeleijn E; Pelsers MM; Soenen S; Mensink M; Bouwman FG; Kooi ME; Saris WH; Glatz JF; Blaak EE
J Physiol Pharmacol; 2008 Mar; 59(1):77-83. PubMed ID: 18441389
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
[TBL] [Abstract][Full Text] [Related]
12. High insulin levels are required for FAT/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes.
Buqué X; Cano A; Miquilena-Colina ME; García-Monzón C; Ochoa B; Aspichueta P
Am J Physiol Endocrinol Metab; 2012 Aug; 303(4):E504-14. PubMed ID: 22693206
[TBL] [Abstract][Full Text] [Related]
13. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
14. CD36 expression contributes to age-induced cardiomyopathy in mice.
Koonen DP; Febbraio M; Bonnet S; Nagendran J; Young ME; Michelakis ED; Dyck JR
Circulation; 2007 Nov; 116(19):2139-47. PubMed ID: 17967771
[TBL] [Abstract][Full Text] [Related]
15. Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity.
Zadravec D; Brolinson A; Fisher RM; Carneheim C; Csikasz RI; Bertrand-Michel J; Borén J; Guillou H; Rudling M; Jacobsson A
FASEB J; 2010 Nov; 24(11):4366-77. PubMed ID: 20605947
[TBL] [Abstract][Full Text] [Related]
16. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
[TBL] [Abstract][Full Text] [Related]
17. Metabolic changes in human CD36 deficiency displayed by glucose loading.
Yanai H; Chiba H; Fujiwara H; Morimoto M; Takahashi Y; Hui SP; Fuda H; Akita H; Kurosawa T; Kobayashi K; Matsuno K
Thromb Haemost; 2001 Oct; 86(4):995-9. PubMed ID: 11686358
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation.
Hong J; Jeppesen PB; Nordentoft I; Hermansen K
Diabetes Metab Res Rev; 2007 Mar; 23(3):202-10. PubMed ID: 16802400
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
[TBL] [Abstract][Full Text] [Related]
20. Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo.
Luangrath V; Brodeur MR; Rhainds D; Brissette L
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1290-5. PubMed ID: 18436808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
